Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2025-12-29 @ 7:11 PM
Study NCT ID:
NCT05247957
Status:
TERMINATED
Last Update Posted:
2023-01-13
First Post:
2022-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
Hangzhou Cheetah Cell Therapeutics Co., Ltd
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CARNK-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None